Ping An Healthcare posts 1.16 billion RMB Q1 revenue; adjusted profit rises 45.8%

Bulletin Express
04/23

Ping An Healthcare and Technology Company Limited reported continued top-line and earnings growth for the three months ended 31 March 2026, underpinned by deeper “insurance + health care” integration and expanding corporate services.

Revenue and earnings • Revenue reached 1.16 billion RMB, up 9.1% from 1.06 billion RMB a year earlier. • Net profit surged to 79.11 million RMB, a 138.4% increase. • Adjusted net profit (excluding share-based payments and FX losses) advanced 45.8% to 84.36 million RMB.

Growth catalysts • Commercial insurance enablement: Enhanced membership services and scenario-based marketing with Ping An Group supported product appeal and client acquisition. • Corporate health management: Number of paying corporate clients in the past 12 months exceeded 7,500, an expansion of nearly 89% year on year, driving higher gross merchandise value.

Ecosystem expansion • “Online” channel: AI Doctor user base grew to more than 5.6 million. • “In-hospital”: QR-code payment coverage widened to 111,000 pharmacies nationwide, facilitating offline medicine purchases for corporate health clients. • “In-home”: Users entitled to home-based senior care services exceeded 290,000. • “In-company”: Additional Workplace Clinics were opened to bolster on-site employee health services.

Technology and service quality The company strengthened its “AI + real doctors” model, achieving an approximately 95% accuracy rate for complex disease diagnosis and treatment plans on its multidisciplinary team (MDT) platform. Further AI deployment is planned across medical services and insurance-healthcare product innovation.

Status of information All figures are unaudited and derived from the Board’s preliminary review of internal data. Ping An Healthcare advised shareholders and potential investors to exercise caution when dealing in the company’s shares.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10